12/18/2024 4:01 PM | Immunovant (Issuer) Van Tuyl Christopher (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/18/2024 4:02 PM | Immunovant (Issuer) Van Tuyl Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:11 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:12 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:09 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2024 3:08 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 4:11 PM | Gloria Melanie (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
|
11/20/2024 4:15 PM | Gloria Melanie (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2024 5:42 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 5:49 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024 3:21 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 3:23 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 3:25 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:27 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:28 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:30 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:31 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 6:40 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2024 3:15 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:12 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 3:19 PM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024 3:17 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:19 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:20 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:36 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:38 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:39 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:41 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:42 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:04 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:06 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 4:07 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 5:56 AM | Immunovant (Filer)
| Form DEF 14A | |
06/26/2024 6:01 AM | Immunovant (Filer)
| Form DEFA14A | |
05/29/2024 3:36 PM | Immunovant (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/26/2024 4:22 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:20 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:57 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:59 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:01 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Elon Musk’s next tweet could help pay for your retirement (Ad) Elon Musk says the government is going bankrupt.
Seniors are getting crushed by inflation. But there is a way you could claim a chunk of over $1 trillion in spending, courtesy of Elon Musk. |
04/19/2024 5:05 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:06 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:18 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:14 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:16 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:54 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:31 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:34 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:37 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:39 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:44 PM | Immunovant (Issuer) Torti Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:46 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:48 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:50 PM | Hughes Douglas J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:23 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:27 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:29 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:14 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:21 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:47 AM | Deep Track Capital, LP (Filed by) Immunovant (Subject)
| Form SC 13G/A | |
02/12/2024 6:02 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:05 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/09/2024 8:16 AM | Immunovant (Subject)
| Form SC 13G | |
01/19/2024 3:04 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:29 AM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/12/2024 3:34 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:18 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:20 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:08 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |